is trizepatide a glp-1 Tirzepatide, New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review GLP-1 medications like semaglutide and

And these digestive symptoms (nausea, constipation, diarrhea) are extremely common, which is why gut support is so important

Abstract Purpose of Review This review summarizes recent advances in the clinical applications of glucagon-like peptide-1 receptor agonists (GLP-1RAs) beyond their established role in glycemic control for type 2 diabetes (T2DM)

In the STEP 1 extension, participants regained around two-thirds of the weight lost within a year of stopping semaglutide, returning to a ~5.6% net loss over two years

For many, the pendulum of health, groceries, and budget remains a zero-sum (or net zero-grocery bill) game

Introduction: the state of obesity in 2023

To view or add a comment, sign in 88% of self-funded employers face stop-loss claims annually, highlighting the prevalence of high-cost health events Learn about top health conditions, injectable drugs and strategies to improve employee wellbeing while controlling costs